Skip to content
VuFind
Advanced
  • Probiotics decreased the bioav...
  • Cite this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats
QR Code

Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats

Bibliographic Details
Main Authors: Al-Salami, Hani, Butt, G., Tucker, I., Golocorbin-Kon, S., Mikov, M.
Format: Journal Article
Published: SpringerLink 2012
Online Access:http://hdl.handle.net/20.500.11937/49027
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://hdl.handle.net/20.500.11937/49027

Similar Items

  • Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics
    by: Mikov, M., et al.
    Published: (2017)
  • Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics
    by: Al-Salami, Hani, et al.
    Published: (2008)
  • Bile acids and probiotics could help treating diabetes
    by: Calasan, J., et al.
    Published: (2012)
  • Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats
    by: Al-Salami, Hani, et al.
    Published: (2008)
  • Application of bile acids in drug formulation and delivery
    by: Stojancevic, M., et al.
    Published: (2014)

Search Options

  • Advanced Search

Find More

  • Browse the Catalog

Need Help?

  • Search Tips